DFCM
TLSI icon

Dark Forest Capital Management’s TriSalus Life Sciences TLSI Stock Holding History

Dark Forest Capital Management’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-348,547
Closed -$3.56M – 1396
2023
Q1 		$3.56M Hold
348,547
– – 0.85% 14
2022
Q4 		$3.5M Hold
348,547
– – 0.86% 29
2022
Q3 		$3.46M Buy
348,547
+63,458
+22% +$628K 0.59% 32
2022
Q2 		$2.81M Buy
285,089
+27,130
+11% +$267K 0.59% 32
2022
Q1 		$2.53M Buy
257,959
+257,359
+42,893% +$2.54M 0.59% 28
2021
Q4 		$6K Sell
600
-13,062
-96% -$130K ﹤0.01% 1114
2021
Q3 		$136K Buy
+13,662
New +$134K 0.05% 310

Other funds holding TLSI

MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $780M AUM 24.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Dark Forest Capital Management's TLSI Position: Q2 2023 in Review

Dark Forest Capital Management sold out of TriSalus Life Sciences (TLSI) in Q2 2023, closing a stake of 348,547 shares — an estimated $3.56M sold.

Dark Forest Capital Management first reported a position in TLSI in Q3 2021 and held it in 7 quarters. The position peaked at $3.56M in Q1 2023. 6 funds tracked by Wall St. Rank hold TLSI as of Q2 2023.

  • Dark Forest Capital Management reported no remaining TriSalus Life Sciences position as of Q2 2023 after selling out during the quarter.
  • Dark Forest Capital Management sold 348,547 TriSalus Life Sciences shares in Q2 2023, an estimated $3.56M.
  • Dark Forest Capital Management first reported a position in TriSalus Life Sciences in Q3 2021 and held it in 7 quarters.
  • Dark Forest Capital Management's TriSalus Life Sciences position peaked at $3.56M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2023.

Based on Dark Forest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.